AMD3100, a potent and specific CXCR4 antagonist, inhibits autoimmune joint inflammation in mice

Patrick Matthys; Sigrid Hatse; Kurt Vermeire; Anja Wuyts; Gary Bridger; De Clercq Erik; Alfons Billiau; Dominique Schols

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2001

AMD3100, a Potent and Specific Antagonist of the Stromal Cell-Derived Factor-1 Chemokine Receptor CXCR4, Inhibits Autoimmune Joint Inflammation in IFN-γ Receptor-Deficient Mice

Patrick Matthys, Sigrid Hatse, Kurt Vermeire, Anja Wuyts, Gary Bridger, Geoffrey Henson, De Clercq Erik, Alfons Billiau, Dominique Schols

Article2002

Inhibition of autoimmune joint inflammation in mice by an antagonist of the SDF-1 chemokine receptor CXCR4

Patrick Matthys, Sigrid Hatse, Kurt Vermeire, Anja Wuyts, Gary Bridger, G Henson, De Clercq Erik, Alfons Billiau, Dominique Schols

Article2005

Potential Clinical Applications of the CXCR4 Antagonist Bicyclam AMD3100

De Clercq Erik

Article2000

The CXCR4 Antagonist AMD3100 Efficiently Inhibits Cell-Surface-Expressed Human Immunodeficiency Virus Type 1 Envelope-Induced Apoptosis

Julià Blanco, Jordi Barretina, Geoffrey Henson, Gary Bridger, De Clercq Erik, Bonaventura Clotet, José A. Esté

Article2005

AMD3465, a monomacrocyclic CXCR4 antagonist and potent HIV entry inhibitor

Sigrid Hatse, Katrien Princen, De Clercq Erik, Mette M. Rosenkilde, Thue W. Schwartz, Pedro E. Hernandez-Abad, Renato T. Skerlj, Gary Bridger, Dominique Schols